Related Experiment Video
Updated: Aug 23, 2026

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
Mitral stenosis with severe pulmonary hypertension
S S Kabbani1, T Bashour, R Dunlap
1Cardiovascular Surgical Center, Damascus Medical School, Damascus, Syria.
Insights
Severe mitral stenosis can cause high pulmonary artery pressures, leading to pulmonary hypertension or low cardiac output. Surgical intervention offers potential for good long-term outcomes in select patients.
Area of Science:
- Cardiology
- Pulmonary Hypertension
- Valvular Heart Disease
Background:
- Mitral valve disease is a significant cause of cardiac morbidity.
- Pulmonary hypertension is a serious complication of mitral stenosis.
- High pulmonary artery pressures impact patient prognosis and management.
Purpose of the Study:
- To investigate the clinical presentation and outcomes of patients with mitral stenosis and severe pulmonary hypertension.
- To evaluate the efficacy of surgical interventions in this patient cohort.
Main Methods:
- Retrospective analysis of 512 patients with mitral valve disease undergoing catheterization.
- Identification of 85 patients with mitral stenosis and systolic pulmonary artery pressures >= 100 mm Hg.
- Review of surgical procedures and perioperative management, including nitroprusside infusion.
Main Results:
- 85 patients had mitral stenosis with severe pulmonary hypertension (>= 100 mm Hg).
- Majority presented with New York Heart Association Class IV (51.8%) or Class III (35.3%) symptoms.
- Pulmonary hypertension symptoms were prominent in 56.5%; low cardiac output syndrome in the remainder.
- 40 patients underwent surgery (commissurotomy, mitral valve replacement, double valve replacement).
- Overall operative mortality was 15%; good long-term results in 30 patients.
Conclusions:
- Mitral stenosis with severe pulmonary hypertension presents with significant symptoms and carries a high operative risk.
- Surgical management, including valve repair or replacement, can lead to good long-term outcomes in carefully selected patients.
- Perioperative support, such as nitroprusside infusion, may improve survival in critical cases.
Abstract:
Consecutive catheterizations in 512 patients with mitral valve disease revealed 85 cases of mitral stenosis with systolic pulmonary artery pressures equal to or in excess of 100 mm Hg. Forty-four patients (51.8%) were in New York Heart Association functional Class IV; 30 (35.3%) were in Class III; and 11 (12.9%) were in Class II. Symptoms related to pulmonary capillary hypertension were prominent in 48 patients (56.5%) while the remaining patients showed signs of low cardiac output syndrome. Forty patients underwent surgery: mitral commissurotomy was performed in 26 patients; mitral valve replacement in 10 patients, and double valve replacement in four patients. Nitroprusside was infused into the pulmonary artery in six patients with severe perioperative low cardiac output; four of these patients survived. The overall operative mortality was 15% (six patients). Good long-term results were achieved in 30 cases.
Related Concept Videos
Mitral Stenosis I: Introduction
Mitral Stenosis IV: Nursing Management
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis III: Medical Management
Mitral Regurgitation I: Introduction
Mitral Regurgitation III: Medical Management

